12994-0 |
Oxychlordane |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Oxychlordane [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
12994-0 |
|
|
|
|
Both |
|
|
|
0 |
Oxychlordane Bld-mCnc |
|
|
|
Y |
|
Blood; Chlordane metabolite; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Octachlor epoxide; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
12995-7 |
Cyclohexanone |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Cyclohexanone [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
12995-7 |
|
|
|
|
Both |
|
|
|
0 |
Cyclohexanone Bld-mCnc |
|
|
|
Y |
|
Anone; Blood; C6H10O; Cyclohexyl ketone; DRUG/TOXICOLOGY; Drugs; Hexanon; Hytrol O; Ketocyclohexane; Ketohexamethylene; Level; Mass concentration; Nadone; Oxocyclohexane; Pimelic ketone; Point in time; QNT; Quan; Quant; Quantitative; Random; Sextone; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
12996-5 |
Dichlorodifluoroethane |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Dichlorodifluoroethane [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
12996-5 |
|
|
|
|
Both |
|
|
|
0 |
DCDFE Bld-mCnc |
|
|
|
Y |
|
Blood; DCDFE; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
12997-3 |
1,4-Dioxane |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
1,4-Dioxane [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
12997-3 |
|
|
|
|
Both |
|
|
|
0 |
1,4Dioxane SerPl-mCnc |
|
|
|
Y |
|
1,4-Diethylene Dioxide; 1,4-Diethylene oxide; 1,4-Dioxacyclohexane; 1,4Dioxane; Diethylene ether; Dioxan; DRUG/TOXICOLOGY; Drugs; Glycol ethylene ether; i; Level; Mass concentration; p-dioxane; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tetrahydro-1,4-dioxin; Tetrahydro-p-dioxin |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
12998-1 |
Methylene chloride |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Methylene chloride [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
12998-1 |
|
|
|
|
Both |
|
|
|
0 |
DCM Bld-mCnc |
|
|
|
Y |
|
Addiction; Blood; Cl; Cl-; DCM; Dichloromethane; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
12999-9 |
Epichlorohydrin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Epichlorohydrin [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
12999-9 |
|
|
|
|
Both |
|
|
|
0 |
Epichlorohydrin SerPl-mCnc |
|
|
|
Y |
|
1-Chloro-2,3-epoxypropane; Allyl chloride oxide; C3H5ClO; Chloro-1,2-epoxypropane; Chloropropyl epoxide; Chloropropylene; DRUG/TOXICOLOGY; Drugs; ECH; Epi; Epichlorhydrin; Epoxy-3-chloropropane; Glycidyl chloride; Level; Mass concentration; Oxirane, 2-(chloromethyl)-; Pl; Plasma; Plsm; Point in time; Propylene oxide; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
13-3 |
Amikacin |
Susc |
Isolate |
Pt |
OrdQn |
Agar diffusion |
|
ACTIVE |
Amikacin [Susceptibility] by Disk diffusion (KB) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
13-3 |
|
Agar diffusion |
|
|
Observation |
|
|
|
0 |
Amikacin Islt KB |
|
|
|
|
|
Amikin; Aminoglycosides; ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
130-5 |
Cefsulodin |
Titr |
Isolate+Ser |
Pt |
SemiQn |
SBT |
|
ACTIVE |
Cefsulodin [Susceptibility] by Serum bactericidal titer |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
ABXBACT |
|
130-5 |
|
SBT |
|
|
Observation |
|
|
|
0 |
Cefsulodin Titr SBT |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; Cefsulodine; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Islt; Isol; Monaspor; Point in time; Pseudocef; Pyocefal; Random; Sequence based typing; Serum; SERUM BACTERICIDAL TITER; Serum killing test; SmQn; SR; Sulcephalosporin; Takesulin; Titer; Titered; Titre; Ttr |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
1300-3 |
PP1 Ab |
ACnc |
Ser/Plas^BPU |
Pt |
Ord |
Aggl RBC |
|
DEPRECATED |
Deprecated PP1 Ab [Presence] in Serum or Plasma from Blood product unit |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1300-3 |
|
Aggl RBC |
|
|
|
|
|
|
0 |
Deprecated PP1 Ab SerPl BPU Ql |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR |
2.4 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
13000-5 |
Mandelate |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Mandelate [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
13000-5 |
|
|
|
|
Both |
|
|
|
0 |
Mandelate Ur-mCnc |
|
|
|
Y |
|
Chemistry; Level; Mandelic acid; Mandilic acid; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
13001-3 |
Mandelate/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Mandelate/Creatinine [Mass Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
13001-3 |
|
|
|
|
Both |
|
|
|
0 |
Mandelate/Creat Ur |
|
|
|
Y |
|
Chemistry; CR; Crea; Creat; Mandelic acid; Mandilic acid; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
Release 2.69: Status: Updated Status from DISCOURAGED to ACTIVE since this term correctly describes existing assays.; |
0 |
13002-1 |
Mesityl oxide |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Mesityl oxide [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
DRUG/TOX |
|
13002-1 |
|
|
|
|
Both |
|
|
|
0 |
Mesityl Oxide Bld-mCnc |
|
|
|
Y |
|
4-methyl-3-penten-2-one; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
13003-9 |
Hydrocarbons.halogenated |
Prid |
Bld |
Pt |
Nom |
|
|
ACTIVE |
Halogenated organic molecules [Identifier] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
13003-9 |
|
|
|
|
Both |
|
|
|
0 |
Halog HC Bld |
|
|
|
|
|
Blood; DRUG/TOXICOLOGY; Drugs; Halog HC; Identity or presence; Nominal; Point in time; Random; WB; Whole blood |
2.15 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
13004-7 |
Hydrocarbons.halogenated.volatile |
Prid |
Bld |
Pt |
Nom |
|
|
ACTIVE |
Hydrocarbons.halogenated.volatile [Identifier] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
13004-7 |
|
|
|
|
Both |
|
|
|
0 |
Vol Halog HC Bld |
|
|
|
|
|
Blood; DRUG/TOXICOLOGY; Drugs; Halog HC; Identity or presence; Nominal; Point in time; Random; Vol Halog HC; Volatiles; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
13005-4 |
2,4,5-Trichlorophenoxyacetate |
Type |
Ser/Plas |
Pt |
Nom |
|
|
ACTIVE |
2,4,5-Trichlorophenoxyacetate [Type] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
13005-4 |
|
|
|
|
Observation |
|
|
|
0 |
2,4,5T SerPl |
|
|
|
|
|
2,4,5T; 2,4,5-T; 2,4,5-trichlorophenoxyacetic acid; 2,4,5-Trichlorophen-oxyacetic acid; Agent orange; DRUG/TOXICOLOGY; Drugs; Herbicide.2,4,5-T; II; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TCPA; Typ |
2.15 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
13006-2 |
1,4-Dichlorobenzene |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
1,4-Dichlorobenzene [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
13006-2 |
|
|
|
|
Observation |
|
|
|
0 |
1,4DCB SerPl-mCnc |
|
|
|
Y |
|
1,4DCB; 3,3'-dichlorobenzidine; C6H4Cl2; DCB; Dichloricide; Dichlorocide; DRUG/TOXICOLOGY; Drugs; Evola; Globol; i; Level; Mass concentration; Para; Para dichlorobenzene; Paracide; Paradow; Paramoth; Paranuggets; Para-zene; p-chlorophenyl chloride; PDB; PDCB; p-DCB; p-dichlorobenzene; p-dichlorobenzol; Persia-perazol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Santochlor; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1.0j-a |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
13007-0 |
Ethane |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Ethane [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
13007-0 |
|
|
|
|
Both |
|
|
|
0 |
Ethane Bld-mCnc |
|
|
|
Y |
|
Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.34 |
1.0j-a |
|
|
|
|
|
|
|
|
|
|
|
0 |
13008-8 |
Methyl propyl ketone |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Methyl propyl ketone [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13008-8 |
|
|
|
|
Both |
|
|
|
0 |
MPK Bld-mCnc |
|
|
|
Y |
|
2-pentanone; Blood; DRUG/TOXICOLOGY; Drugs; Ethylacetone; Level; Mass concentration; Methyl n-propyl ketone; Methylpropyl ketone; MPK; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
13009-6 |
Methyl ethyl ketone |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Methyl ethyl ketone [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13009-6 |
|
|
|
|
Both |
|
|
|
0 |
MEK Ur-mCnc |
|
|
|
Y |
|
2-Butanone; 3-butanone; Butanone; DRUG/TOXICOLOGY; Drugs; Ethyl methyl ketone; Level; Mass concentration; MEK; Methyl acetone; Methylethylketone; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
1301-1 |
PP1 Ab |
ACnc |
Ser/Plas^Donor |
Pt |
Ord |
Aggl RBC |
|
DEPRECATED |
Deprecated PP1 Ab [Presence] serum or plasma from donor |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
1301-1 |
|
Aggl RBC |
|
|
|
|
|
|
0 |
Deprecated PP1 Ab SerPl Donr Ql |
|
|
|
|
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; BLOOD BANK; Donr; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.4 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
13010-4 |
Methyl amyl ketone |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Methyl amyl ketone [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13010-4 |
|
|
|
|
Both |
|
|
|
0 |
MAK Bld-mCnc |
|
|
|
Y |
|
2-heptanone; Blood; Butylacetone; DRUG/TOXICOLOGY; Drugs; Level; MAK; Mass Concentration; Methyl n-amyl ketone; N-amyl methyl ketone; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
13011-2 |
Methyl ethyl ketone |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Methyl ethyl ketone [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13011-2 |
|
|
|
|
Both |
|
|
|
0 |
MEK Bld-mCnc |
|
|
|
Y |
|
2-Butanone; 3-butanone; Blood; Butanone; DRUG/TOXICOLOGY; Drugs; Ethyl methyl ketone; Level; Mass concentration; MEK; Methyl acetone; Methylethylketone; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
13012-0 |
Methyl isoamyl ketone |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Methyl isoamyl ketone [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13012-0 |
|
|
|
|
Both |
|
|
|
0 |
MIAK Bld-mCnc |
|
|
|
Y |
|
2-methyl-5-hexanone; Blood; DRUG/TOXICOLOGY; Drugs; Isoamyl methyl ketone; Isopentyl methyl ketone; Level; Mass concentration; MIAK; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
13013-8 |
Methyl isobutyl ketone |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Methyl isobutyl ketone [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13013-8 |
|
|
|
|
Both |
|
|
|
0 |
MIBK Bld-mCnc |
|
|
|
Y |
|
2-methyl-4-pentanone; 2-methylpropyl methyl ketone; 4-methyl-2-oxopentane; 4-methyl-2-pentanone; Blood; DRUG/TOXICOLOGY; Drugs; Isobutyl methyl ketone; Isopropyl acetone; Level; Mass concentration; MIBK; MIK; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
13014-6 |
Methyl butyl ketone |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Methyl butyl ketone [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
13014-6 |
|
|
|
|
Both |
|
|
|
0 |
MNBK Bld-mCnc |
|
|
|
Y |
|
2-oxohexane; Blood; Butyl methyl ketone; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; MBK; Methyl n-butyl ketone; MNBK; Point in time; Propylacetone; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0j-a |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |